Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Clinical parameters of HIV-infected subjects included in the HIV primary infection (HPI) cohort

From: Impaired Th17 polarization of phenotypically naive CD4+ T-cells during chronic HIV-1 infection and potential restoration with early ART

Subjects Visit # CD4 counts 1 Plasma viral load 2 Time since infection 3 Time since inclusion 3 ART
HPI 01 V1 430 35,303 2.5 0 No
  V2 520 2,301 3 1 No
ART at 8 months since infection V3 450 24,845 3.5 2 No
V4 350 38,395 4 3 No
V8 310 681 9 7 Yes
V9 690 40 12 10 Yes
V11 690 40 21 16 Yes
V12 - 40 21.5 19 Yes
V13 650 40 24 22 Yes
V14 - - 27 25 Yes
HPI 02 V1 407 189,343 2.5 0 No
  V2 430 173,044 3.5 1 No
ART at 9.5 months since infection V3 403 59,181 4 2 No
V7 396 81,037 6.5 4 No
V9 467 74 11.5 9 Yes
V10 496 50 13 11 Yes
V11 516 50 16 13 Yes
V12 567 50 20 17 Yes
HPI 03 V1 580 86,627 1.5 0 No
  V2 540 37,335 2.5 1 No
ART at 11.5 months since infection V4 740 27,348 3 2 No
V5 730 20,076 3.5 3 No
V7 670 11,127 5.5 5 No
V8 530 26,574 7.5 7 No
V9 460 85,718 10.5 10 No
V10 380 664 13.5 13 Yes
V11 660 113 17 17 Yes
V12 640 40 20 19 Yes
V13 780 40 22 22 Yes
HPI 04 V1 240 29,981,000 1 0 No
  V3 700 129,717 2 1 No
ART at 4.5 months since infection V4 340 76,626 2.5 2 No
V7 650 712 5.5 5 Yes
V11 670 40 16 15 Yes
V12 870 40 19 18 Yes
V13 830 40 22 21 Yes
V14 - - 25 24 Yes
  1. 1, cells/μL; 2, HIV-RNA copies per mL plasma (log10); 3, months; ART, antiretroviral therapy.